Just going over a few recent past quarterlies and was wondering, does it concern anyone that the combined total income from the sales of the Personal WheezoMeter™, the WHolter™ and the PulmoTrack® for last quarter was only $4,000 compared to $81,000 in the previous quarter??
Something deffenatly not right there and seems like these products are not selling as well as they hoped hence maybe the reason they are turning all their focus to marketing the wheezometer??
And does it also concern holders that on the 23/8/2011 in a company annoucement they stated that "One of these partnerships (Omron) has already been announced. We will announce several others prior to the end of this calendar year." Which clearly hasnt happened and another concern about the abilitites of management. (The MOU with a fortune 500 company isnt worth the paper its written on so clearly cant be classified as a partnership untill hard contracts and deals are written up)
- Forums
- ASX - By Stock
- another 90m shares issued at .3c
Just going over a few recent past quarterlies and was wondering,...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ISN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online